Importer of Controlled Substances; Notice of Application; Correction
---
identifier: "/us/fr/E7-309"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances; Notice of Application; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "E7-309"
section_name: "Importer of Controlled Substances; Notice of Application; Correction"
positive_law: false
currency: "2007-01-12"
last_updated: "2007-01-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "E7-309"
document_type: "notice"
publication_date: "2007-01-12"
agencies:
- "Justice Department"
- "Drug Enforcement Administration"
fr_citation: "72 FR 1560"
fr_volume: 72
---
# Importer of Controlled Substances; Notice of Application; Correction
By Notice dated November 21, 2006, and published in the *Federal Register* on December 1, 2006, (71 FR 69590), Notice of Application, Hospira, Inc., 1776 North Centennial Drive, McPherson, Kansas 67460-1247, paragraph three should be corrected to read as follows: The company plans to import Remifentanil for use in dosage form manufacturing.
Dated: January 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.